Prognostic biomarkers to identify patients destined to develop severe Crohn’s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Taylor, Stuart A.
Funding for this research was provided by:
Health Technology Assessment Programme (14/210/07)
unspecified valid from 2016-12-01